Bayer improves its valuation following Roundup legal relief
Bayer (XETRA: BAYN) improves its valuation following Roundup legal relief
Ion Jauregui – Analyst at ActivTrades
Bayer shares posted a strong rally after the company announced the creation of Ruveon, a new entity that will consolidate its U.S. glyphosate business, which includes the Roundup brand
Bayer AG
No trades
No trades
Compare with Bayer AG
−2.19 EUR
−3.62 B EUR
45.58 B EUR
982.42 M
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
Details
Sector
Industry
CEO
William N. Anderson
Website
Headquarters
Leverkusen
Founded
1952
IPO date
Nov 28, 1997
ISIN
DE000BAY0017
FIGI
BBG00GY18HF2
Identifiers
ISIN DE000BAY0017
Bayer AG engages in the business of life science fields of healthcare and nutrition. It operates through the following segments: Crop Science, Pharmaceuticals, and Consumer Health. The Crop Science segment includes developing, producing, and marketing products in seeds and plant traits, crop protection, digital solutions, and customer services to promote sustainable agriculture. The Pharmaceuticals segment is involved in prescription products especially for cardiology and women’s health; specialty therapeutics in the areas of oncology, hematology, ophthalmology, and cell and gene therapy; diagnostic imaging equipment; and necessary contrast agents. The Consumer Health segment focuses on non-prescription products in the dermatology, nutritional supplements, digestive health, allergy, cough and cold, and pain and cardiovascular risk prevention categories. The company was founded by Friedrich Bayer and Johann Friedrich Westkott on August 1, 1863 and is headquartered in Leverkusen, Germany.
Bayer AG — Harmonic Pattern with VWAP / Gartley ConfluenceBayer has developed a harmonic pattern structure, and the current price action suggests that the next relevant technical area is located below the current market price.
The preferred scenario is that price continues to move toward the projected VWAP area. This zone is especially important because t
Bayer AG Seeks to Close the Roundup Legal FrontIon Jauregui – Analyst at ActivTrades
German pharmaceutical and agrochemical giant Bayer is back in the spotlight after announcing a new effort to resolve the long-running litigation in the United States over the herbicide Roundup. The company has proposed a settlement of up to $7.25 billion to re
Bayer-4h timeframe-bullish continuation
Looks like Bayer is moving higher with wave 5 green, target 53.
Bayer has been my favourite stock to analyze and trade. Recently I feel like assigning the personality traits of the asset I analyse. And this is Bayer personality.
✅ Interestingly, Bayer is a big German pharma corporation. And its p
Bayer bullish continuation 1H timeframe, target 51✅ Bingoooo
Another correct prediction. Bayer is currently trading at 45.5, 26% gain since I made this post. The next target is at 51, and I expect a correction on the lower timeframe at that level.
Upside for Bayer is still massive, with correction in lower timeframe along the way, of course.
Inval
BAYER: Wave (X) CompleteBayer shares have continued their bullish momentum since our last update. As shown on the daily chart, we now primarily believe that the low of wave (X) in blue is already in place, and that the next phase will see wave (Y) advancing above all marked resistance lines.
As a result, we have deactivat
Late cycle. Medicine ++In November 2023, it was reported that German chemical concern Bayer AG was considering options for splitting the business due to weak financial performance.
Management considered several options:
spinning off the health products or agricultural fertilizer businesses into a separate company;
Bottom up with clear upside momentumXETR:BAYN Bayer is looking at a possible rebound after the stock rose strongly and attempting to break above the bearish gap seen.
Ichimoku is showing a strong bullish signal and we believe near-term should see further upside.
Long-term MACD is back to the positive. Stochastic confirms the bull
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
7.355% YTM
Maturity dateJul 15, 2064
Coupon4.70% (Fixed)
7.038% YTM
Maturity dateNov 15, 2043
Coupon4.65% (Fixed)
6.930% YTM
Maturity dateJul 15, 2042
Coupon3.60% (Fixed)
6.779% YTM
Maturity dateJul 15, 2044
Coupon4.40% (Fixed)
6.711% YTM
Maturity dateApr 15, 2045
Coupon3.95% (Fixed)
6.607% YTM
Maturity dateJun 25, 2048
Coupon4.88% (Fixed)
6.578% YTM
Maturity dateJul 15, 2064
Coupon4.70% (Fixed)
6.566% YTM
Maturity dateJun 25, 2048
Coupon4.88% (Fixed)
6.556% YTM
Maturity dateNov 21, 2053
Coupon6.88% (Fixed)
6.542% YTM
Maturity dateApr 15, 2045
Coupon3.95% (Fixed)
6.516% YTM
Maturity dateJul 15, 2044
Coupon4.40% (Fixed)
See all BAYN bonds
Weight0.12%
Market value800.24 M
Weight0.17%
Market value532.15 M
Weight6.41%
Market value509.20 M
Weight0.21%
Market value381.63 M
Weight2.64%
Market value257.47 M
Weight2.64%
Market value257.47 M
Weight2.69%
Market value212.50 M
Weight2.69%
Market value212.50 M
Weight0.95%
Market value196.23 M
Weight0.24%
Market value182.02 M
Weight1.05%
Market value144.03 M
Explore more ETFs
Frequently asked questions
The current price of BAYN is 46.16 EUR — it has decreased by −0.17% in the past 24 hours. Watch Bayer AG stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on VIE exchange Bayer AG stocks are traded under the ticker BAYN.
BAYN stock has fallen by −2.31% compared to the previous week, the month change is a 18.91% rise, over the last year Bayer AG has showed a 63.11% increase.
We've gathered analysts' opinions on Bayer AG future price: according to them, BAYN price has a max estimate of 65.00 EUR and a min estimate of 46.00 EUR. Watch BAYN chart and read a more detailed Bayer AG stock forecast: see what analysts think of Bayer AG and suggest that you do with its stocks.
BAYN reached its all-time high on Jun 23, 2017 with the price of 120.75 EUR, and its all-time low was 18.22 EUR and was reached on Dec 20, 2024. View more price dynamics on BAYN chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
BAYN stock is 1.31% volatile and has beta coefficient of 0.57. Track Bayer AG stock price on the chart and check out the list of the most volatile stocks — is Bayer AG there?
Today Bayer AG has the market capitalization of 45.25 B, it has decreased by −2.92% over the last week.
Yes, you can track Bayer AG financials in yearly and quarterly reports right on TradingView.
Bayer AG is going to release the next earnings report on Aug 4, 2026. Keep track of upcoming events with our Earnings Calendar.
BAYN earnings for the last quarter are 2.71 EUR per share, whereas the estimation was 2.31 EUR resulting in a 17.21% surprise. The estimated earnings for the next quarter are 0.77 EUR per share. See more details about Bayer AG earnings.
Bayer AG revenue for the last quarter amounts to 13.40 B EUR, despite the estimated figure of 13.47 B EUR. In the next quarter, revenue is expected to reach 10.73 B EUR.
BAYN net income for the last quarter is 2.76 B EUR, while the quarter before that showed −3.76 B EUR of net income which accounts for 0.00% change. Track more Bayer AG financial stats to get the full picture.
Yes, BAYN dividends are paid annually. The last dividend per share was 0.11 EUR. As of today, Dividend Yield (TTM)% is 0.24%. Tracking Bayer AG dividends might help you take more informed decisions.
As of Jul 25, 2026, the company has 88.08 K employees. See our rating of the largest employees — is Bayer AG on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Bayer AG EBITDA is 9.82 B EUR, and current EBITDA margin is 24.16%. See more stats in Bayer AG financial statements.
Like other stocks, BAYN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Bayer AG stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Bayer AG technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Bayer AG stock shows the buy signal. See more of Bayer AG technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.









